drugset / Trial / NCT00119769

The Effect of Low-Dose Human Growth Hormone Therapy in HIV Infected Patients

NCT00119769

Phase 4 Completed 46 enrolled Hvidovre University Hospital Pfizer · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to investigate the effect of low-dose human growth hormone therapy on immune status and fat morphology.

Timeline

Start
2005-02
Primary completion
2007-05
Completion
2008-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Somatropin Protein / enzyme biologic 0.7 mg Subcutaneous